drugset / Trial / NCT00606749
Use of KC706 for the Treatment of Pemphigus Vulgaris
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether KC706 is effective in the prevention and healing of blisters in patients with pemphigus vulgaris, while the patient remains on stable doses of corticosteroids and/or immunosuppressants.
Timeline
- Start
- 2007-11
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ITX 5061 | Small molecule | 300 mg | — |